Tempus AI, a leading AI biotech company, saw its stock soar 7.55% in the pre-market trading session on Monday. This surge came as AI biotech stocks, including Recursion and Tempus AI, gained momentum in the early trading hours.
The rise in Tempus AI's stock price can be attributed to the growing investor interest in the AI biotech sector. As the adoption of artificial intelligence in various industries continues to accelerate, companies like Tempus AI, which leverage AI for healthcare and biotechnology applications, are garnering significant attention.
Additionally, Tempus AI's strong financial performance and promising growth prospects may have contributed to the stock's surge. The company is expected to release its earnings report later on Monday, further fueling investor enthusiasm surrounding the AI biotech sector.